David Callanan

David Callanan

Company: Aviceda Therapeutics

Job title: CMO

Seminars:

Leveraging Clinical Data to Evaluate a Single Dose Intravitreal Administration of AVD-104 2:00 pm

Assessing the dose escalation and safety data Highlighting the benefits of using our chosen molecule Outlining the trial design for the 2 year trial with a 12 month primary endpointRead more

day: Clinical PM -Day 1

Leveraging Clinical Data to Evaluate a Single Dose Intravitreal Administration of AVD-104 3:00 pm

Assessing the dose escalation and safety data Highlighting the benefits of using our chosen molecule Outlining the trial design for the 2 year trial with a 12 month primary endpointRead more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.